Maze Therapeutics Logo

Maze Therapeutics

🇺🇸
MAZE
US5787841007

Maze Therapeutics is a US-based biotechnology company specializing in the development of innovative therapies for genetic diseases. By leveraging its proprietary "Maze Compass" platform, the company deciphers complex disease drivers to develop precise, targeted medicines for patients in need.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
After-Hours
In 70 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Maze Therapeutics report its next quarterly earnings?

Maze Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Maze Therapeutics last report quarterly earnings?

Maze Therapeutics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.76 USD.

How often has Maze Therapeutics beaten expectations?

Maze Therapeutics has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).

How do I add the Maze Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.76
Actual:
Q2 2026
Missed
Estimate:-$0.72
Actual:-$0.76
Difference:-$0.04
Q1 2026
Beat
Estimate:-$0.58
Actual:-$0.45
Difference:+$0.13
Price reaction (1 day):+4.6 %
Price reaction (7 days):-5.1 %
Q4 2025
Beat
Estimate:-$0.71
Actual:-$0.65
Difference:+$0.06
Price reaction (1 day):-35.2 %
Price reaction (7 days):-40.7 %

Earnings statistics

Estimates vs. results

2/3
Quarters above estimates
66.7%
Beat rate
+8.3%
Avg. EPS surprise

Basis: 3 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Maze Therapeutics
Ticker Symbol
MAZE
ISIN
US5787841007
Country
🇺🇸
USA
Sector